Cargando…
Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440910/ https://www.ncbi.nlm.nih.gov/pubmed/32647053 http://dx.doi.org/10.2337/dc20-0437 |
| _version_ | 1783573205974253568 |
|---|---|
| author | Crowley, Matthew J. McGuire, Darren K. Alexopoulos, Anastasia-Stefania Jensen, Thomas Jon Rasmussen, Søren Saevereid, Hans A. Verma, Subodh Buse, John B. |
| author_facet | Crowley, Matthew J. McGuire, Darren K. Alexopoulos, Anastasia-Stefania Jensen, Thomas Jon Rasmussen, Søren Saevereid, Hans A. Verma, Subodh Buse, John B. |
| author_sort | Crowley, Matthew J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7440910 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74409102021-09-01 Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial Crowley, Matthew J. McGuire, Darren K. Alexopoulos, Anastasia-Stefania Jensen, Thomas Jon Rasmussen, Søren Saevereid, Hans A. Verma, Subodh Buse, John B. Diabetes Care e-Letters: Observations American Diabetes Association 2020-09 2020-07-09 /pmc/articles/PMC7440910/ /pubmed/32647053 http://dx.doi.org/10.2337/dc20-0437 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
| spellingShingle | e-Letters: Observations Crowley, Matthew J. McGuire, Darren K. Alexopoulos, Anastasia-Stefania Jensen, Thomas Jon Rasmussen, Søren Saevereid, Hans A. Verma, Subodh Buse, John B. Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial |
| title | Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial |
| title_full | Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial |
| title_fullStr | Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial |
| title_full_unstemmed | Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial |
| title_short | Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial |
| title_sort | effects of liraglutide on cardiovascular outcomes in type 2 diabetes patients with and without baseline metformin use: post hoc analyses of the leader trial |
| topic | e-Letters: Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440910/ https://www.ncbi.nlm.nih.gov/pubmed/32647053 http://dx.doi.org/10.2337/dc20-0437 |
| work_keys_str_mv | AT crowleymatthewj effectsofliraglutideoncardiovascularoutcomesintype2diabetespatientswithandwithoutbaselinemetforminuseposthocanalysesoftheleadertrial AT mcguiredarrenk effectsofliraglutideoncardiovascularoutcomesintype2diabetespatientswithandwithoutbaselinemetforminuseposthocanalysesoftheleadertrial AT alexopoulosanastasiastefania effectsofliraglutideoncardiovascularoutcomesintype2diabetespatientswithandwithoutbaselinemetforminuseposthocanalysesoftheleadertrial AT jensenthomasjon effectsofliraglutideoncardiovascularoutcomesintype2diabetespatientswithandwithoutbaselinemetforminuseposthocanalysesoftheleadertrial AT rasmussensøren effectsofliraglutideoncardiovascularoutcomesintype2diabetespatientswithandwithoutbaselinemetforminuseposthocanalysesoftheleadertrial AT saevereidhansa effectsofliraglutideoncardiovascularoutcomesintype2diabetespatientswithandwithoutbaselinemetforminuseposthocanalysesoftheleadertrial AT vermasubodh effectsofliraglutideoncardiovascularoutcomesintype2diabetespatientswithandwithoutbaselinemetforminuseposthocanalysesoftheleadertrial AT busejohnb effectsofliraglutideoncardiovascularoutcomesintype2diabetespatientswithandwithoutbaselinemetforminuseposthocanalysesoftheleadertrial |